Nov 7 (Reuters)-
Cosmo Bio Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2025 Sep 30, 2024 Dec 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 7.89 7.41 10.70
(+6.4 pct) (+7.7 pct) (+6.6 pct)
Operating 275 mln 369 mln 490 mln
(-25.4 pct) (-17.5 pct) (+53.8 pct)
Recurring 369 mln 384 mln 580 mln
(-3.9 pct) (-30.6 pct) (+59.2 pct)
Net 272 mln 291 mln 430 mln
(-6.3 pct) (-20.4 pct) (+64.1 pct)
EPS 47.96 yen 49.92 yen 75.77 yen
Ann Div 50.00 yen 50.00 yen
-Q2 div 25.00 yen 14.00 yen
-Q4 div 36.00 yen 25.00 yen
NOTE - Cosmo Bio Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T